MKI67 and cancer: Ki-67 proliferation index is a widely used immunohistochemical test that reflects the activity of tumour cells, aiding the discrimination between low and high grade tumours, treatment response to neoadjuvant radiotherapy and can act as a predictor of clinical outcome in several cancers.